Authors:
Ainsworth, M
Bhamarapravati, N
Batson, A
Bishai, D
Moran-Carpentier, O
Casabona, J
Clemens, J
Collins, C
El Habib, R
Forsythe, S
Goldenthal, K
Kunanusont, C
Longini, IM
Mahoney, R
Mastro, TD
Ndumbe, P
Pallangyo, K
Rowley, J
Sadoff, J
Shin, SI
Pratt, D
Stanton, BF
Suraratdecha, C
Teixeira, PR
van den Bussche, I
Vandermissen, W
Walsh, JA
Whittington, D
Widdus, R
Citation: M. Ainsworth et al., Future access to HIV vaccines - Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000, AIDS, 15(7), 2001, pp. W27-W44
Citation: J. Esparza et N. Bhamarapravati, Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?, LANCET, 355(9220), 2000, pp. 2061-2066
Authors:
Rabablert, J
Dharakul, T
Yoksan, S
Bhamarapravati, N
Citation: J. Rabablert et al., Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines, A P J ALLER, 18(4), 2000, pp. 227-235
Authors:
Butrapet, S
Huang, CYH
Pierro, DJ
Bhamarapravati, N
Gubler, DJ
Kinney, RM
Citation: S. Butrapet et al., Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5 ' noncoding region and nonstructural proteins 1 and 3, J VIROLOGY, 74(7), 2000, pp. 3011-3019
Authors:
Huang, CYH
Butrapet, S
Pierro, DJ
Chang, GJJ
Hunt, AR
Bhamarapravati, N
Gubler, DJ
Kinney, RM
Citation: Cyh. Huang et al., Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine, J VIROLOGY, 74(7), 2000, pp. 3020-3028
Authors:
Jirakanjanakit, N
Khin, MM
Yoksan, S
Bhamarapravati, N
Citation: N. Jirakanjanakit et al., The use of Toxorhynchites splendens for identification and quantitation ofserotypes contained in the tetravalent live attenuated dengue vaccine, VACCINE, 17(6), 1999, pp. 597-601
Authors:
Jirakanjanakit, N
Khin, MM
Yoksan, S
Bhamarapravati, N
Citation: N. Jirakanjanakit et al., Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti, AM J TROP M, 61(4), 1999, pp. 672-676